Exchange: NASDAQ·Updated 10:03 AM EDT
LEGN logo

LEGN Legend Biotech

$18.02
$0.41
(2.33%)
Today
EarningsNov 11
Mkt Cap$3.41B
Vol324,928.00

About LEGN

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
61

Bullish Sentiment

How do you feel about LEGN?

Advertisement|Remove ads.